Could the vaccine help ailing emerging-market shares?
The American election and the news on the jab have renewed investors’ appetite for risk
Editor’s note: Some of our covid-19 coverage is free for readers of The Economist Today, our daily newsletter. For more stories and our pandemic tracker, see our hub
AN INDIAN ECONOMIC official once remarked to Buttonwood that his country’s economy does best when the rest of the world does well—but not too well. India’s exports benefit from global growth. But when the world economy gains too much momentum, interest rates and oil prices can rise uncomfortably high, hobbling a country that is a net importer of both capital and crude.
This article appeared in the Finance & economics section of the print edition under the headline "Coming out of the ultracold"
More from Finance & economics
The property firm that could break China’s back
If Vanke collapses, so might confidence in the state’s management of the economy
Narendra Modi’s flagship growth scheme is off to a sluggish start
Without improvements, it risks wasting trillions of rupees
Diego Maradona offers central bankers enduring lessons
Recent years ought to have reduced the importance of a skilful feint. They have not